পদ্ধতির তুলনা করুন

	FACT-Ovarian: Functional Assessment of Cancer Therapy	EORTC QLQ-BR23: স্তন ক্যান্সারে জীবনযাত্রার মান
ক্ষেত্র	অর্বুদবিজ্ঞান	অর্বুদবিজ্ঞান
পরিবার	Process / pipeline	Process / pipeline
উদ্ভবের বছর	2001	1996
প্রবর্তক	Basen-Engquist, K., et al. (built on Cella, D. F. FACT-G framework)	Sprangers, M. A., et al. (EORTC Quality of Life Group)
ধরন	Self-report questionnaire	Self-report questionnaire
মৌলিক উৎস	Basen-Engquist, K., Bodurka, D. C., Lu, H., Sill, M. W., Thaker, P. H., Deavers, M. T., et al. (2001). Reliability and validity of the Functional Assessment of Cancer Therapy-Ovarian (FACT-O) quality of life instrument. Gynecol Oncol, 89(3), 478–488.	Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol, 14(10), 2756–2768.
অপর নাম	FACT-O	QLQ-BR23
সম্পর্কিত	5	5
সারসংক্ষেপ	The FACT-Ovarian (FACT-O) is a disease-specific quality-of-life measure for women with ovarian cancer, integrating the 27-item FACT-G core with a 12-item ovarian-specific subscale addressing cancer-related symptoms, sexual function, abdominal distension, and treatment side effects. Validated by Basen-Engquist et al. in 2001, it is a standard endpoint in ovarian cancer clinical trials and supportive care research.	The EORTC QLQ-BR23 is a 23-item breast-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire, assessing functional and symptom domains unique to breast cancer. Validated by Sprangers et al. in 1996, it measures body image, sexual function, breast symptoms, and arm symptoms, making it a standard instrument in European and international breast cancer clinical trials and quality-of-life research.